This technological prowess now guarantees the confidentiality of email exchanges between Gmail users and non-users. Fully interoperable, the solution deploys simply and quickly without altering the user experience. With this new advancement, Cosmian strengthens its position as a leader in…
Month: July 2024
This technological prowess now guarantees the confidentiality of email exchanges between Gmail users and non-users. Fully interoperable, the solution deploys simply and quickly without altering the user experience. With this new advancement, Cosmian strengthens its position as a leader in…
ZURICH, July 9, 2024 /PRNewswire/ — Chubb Limited (NYSE: CB) today announced that it has appointed Paul McNamee Executive Vice President, Chubb Group and President, Overseas General Insurance, based out of New York. McNamee will have executive operating responsibility for Chubb’s general…
ZURICH, July 9, 2024 /PRNewswire/ — Chubb Limited (NYSE: CB) today announced that it has appointed Paul McNamee Executive Vice President, Chubb Group and President, Overseas General Insurance, based out of New York. McNamee will have executive operating responsibility for Chubb’s general…
Chris Maleno appointed Vice Chairman, North America Insurance ZURICH, July 9, 2024 /PRNewswire/ — Chubb Limited (NYSE: CB) today announced several executive appointments to its North American general insurance business. John Lupica, Vice Chairman, Chubb Group and President, North America…
Chris Maleno appointed Vice Chairman, North America Insurance ZURICH, July 9, 2024 /PRNewswire/ — Chubb Limited (NYSE: CB) today announced several executive appointments to its North American general insurance business. John Lupica, Vice Chairman, Chubb Group and President, North America…
Factor to reveal engineered iPSC-derived macrophages that enhance T cell cytotoxicity to triple negative breast and ovarian cancer cells Presentations will include latest preclinical data from Factor’s stealth iPSC and nucleic acid delivery platforms CAMBRIDGE, Mass., July 9, 2024…
Factor to reveal engineered iPSC-derived macrophages that enhance T cell cytotoxicity to triple negative breast and ovarian cancer cells Presentations will include latest preclinical data from Factor’s stealth iPSC and nucleic acid delivery platforms CAMBRIDGE, Mass., July 9, 2024…
SCOTTSDALE, Ariz., July 9, 2024 /PRNewswire/ — Resideo Technologies, Inc. (NYSE: REZI) (the “Company” or “Resideo”) today announced that Resideo Funding Inc. (the “Issuer”), a direct wholly-owned subsidiary of the Company, has commenced a private offering of $500 million aggregate…
SCOTTSDALE, Ariz., July 9, 2024 /PRNewswire/ — Resideo Technologies, Inc. (NYSE: REZI) (the “Company” or “Resideo”) today announced that Resideo Funding Inc. (the “Issuer”), a direct wholly-owned subsidiary of the Company, has commenced a private offering of $500 million aggregate…